HRA Pharma may be about to get new owners

22 December 2015 - Deborah Wilkes


Goldman Sachs and private-equity firm Astorg Asset Management may be about to acquire control of HRA Pharma, which recently switched the ellaOne (ulipristal acetate) emergency contraceptive from prescription to non-prescription status in the European Union.

Click tags below for more information on topics:

HRA Pharma

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: